In a report published Monday, J.P. Morgan analyst
Michael Weinstein reiterated an Overweight rating on HeartWare International (NASDAQ: HTWR).In the report, J.P. Morgan noted, “Overall, we view the CAP approval as a positive that should help to alleviate ...
[Published Benzinga.com - Jun 17 2013]